Roche Inks $549M Deal To License 'Superbug' Antibiotic
Biotech giant Roche will pay up to 500 million Swiss francs ($549 million) to Polyphor Ltd. for an exclusive worldwide license agreement to develop and market its drug that targets an...To view the full article, register now.
Already a subscriber? Click here to view full article